CHG

528

+3.33%↑

CHG

528

+3.33%↑

CHG

528

+3.33%↑

CHG

528

+3.33%↑

CHG

528

+3.33%↑

Search

Halma PLC

Gesloten

SectorIndustrieën

3,906 0.98

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3838

Max

3918

Belangrijke statistieken

By Trading Economics

Inkomsten

107M

187M

Verkoop

651M

1.2B

K/W

Sectorgemiddelde

42.528

47.18

EPS

0.553

Dividendrendement

0.61

Winstmarge

15.096

Werknemers

9,000

EBITDA

184M

317M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

-0.61% downside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.61%

2.05%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

823M

15B

Vorige openingsprijs

3905.02

Vorige sluitingsprijs

3906

Nieuwssentiment

By Acuity

50%

50%

192 / 406 Rangschikking in Industrials

Halma PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 feb 2026, 23:44 UTC

Populaire aandelen

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17 feb 2026, 23:20 UTC

Winsten

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17 feb 2026, 22:57 UTC

Winsten

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17 feb 2026, 21:59 UTC

Winsten

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17 feb 2026, 23:54 UTC

Marktinformatie

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17 feb 2026, 23:54 UTC

Marktinformatie

Global Equities Roundup: Market Talk

17 feb 2026, 23:54 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 feb 2026, 23:45 UTC

Marktinformatie

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17 feb 2026, 23:19 UTC

Winsten

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb 2026, 23:15 UTC

Winsten

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb 2026, 22:58 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17 feb 2026, 22:58 UTC

Acquisities, Fusies, Overnames

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17 feb 2026, 22:57 UTC

Acquisities, Fusies, Overnames

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17 feb 2026, 22:50 UTC

Acquisities, Fusies, Overnames

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17 feb 2026, 22:44 UTC

Winsten

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb 2026, 22:42 UTC

Winsten

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17 feb 2026, 22:36 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17 feb 2026, 22:36 UTC

Winsten

Santos Final Dividend 10.3 U.S. Cents/Security

17 feb 2026, 22:36 UTC

Winsten

Santos FY Underlying Profit US$898 Million, Down 25%

17 feb 2026, 22:35 UTC

Winsten

Santos FY Revenue US$4.94 Billion, Down 8%

17 feb 2026, 22:35 UTC

Winsten

Correct: Santos FY Net Profit US$818 Million, Down 33%

17 feb 2026, 22:35 UTC

Acquisities, Fusies, Overnames

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17 feb 2026, 22:34 UTC

Winsten

Santos FY Net Profit US$818 Billion, Down 33%

17 feb 2026, 22:02 UTC

Acquisities, Fusies, Overnames

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17 feb 2026, 21:50 UTC

Acquisities, Fusies, Overnames

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17 feb 2026, 21:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

17 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 feb 2026, 21:49 UTC

Acquisities, Fusies, Overnames

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17 feb 2026, 21:48 UTC

Acquisities, Fusies, Overnames

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17 feb 2026, 21:48 UTC

Acquisities, Fusies, Overnames

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Peer Vergelijking

Prijswijziging

Halma PLC Prognose

Koersdoel

By TipRanks

-0.61% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 3,852.31 GBX  -0.61%

Hoogste 4,280 GBX

Laagste 2,490 GBX

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor Halma PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

13 ratings

7

Buy

5

Hold

1

Sell

Sentiment

By Acuity

192 / 406 Rangschikking in Industrieën

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat